NASDAQ : SRPT

Sarepta Therapeutics, Inc.

$17.61 USD

-$0.35 (-1.95%)

Volume
3.46M
Average Volume
3.29M
Market Capitalization
$1.86B
P/E Ratio
28.40
Dividend Yield
0.00%
Price Target
$25.00
Year High
$25.32
Year Low
$10.42
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.63

SRPT Estimated and Actual Revenue by Quarter

SRPT Estimated and Actual EPS by Quarter

SRPT Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 6 -135.94M -105.99M -118.53M -150.96M -117.7M -131.62M
2027-09-30 6 -134.75M -105.06M -117.49M -149.64M -116.67M -130.47M
2027-06-30 6 -133.27M -103.91M -116.2M -148M -115.39M -129.04M
2027-03-31 6 -131.83M -102.78M -114.94M -146.39M -114.14M -127.64M
2026-12-31 6 -136.2M -106.19M -118.75M -151.24M -117.92M -131.87M
2026-09-30 13 -125.55M -108.51M -117.09M -139.42M -120.5M -130.02M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 6 23.66M 32.67M 27.43M 119.55M 153.33M 133.69M
2027-09-30 6 22.61M 31.22M 26.21M 118.5M 151.99M 132.52M
2027-06-30 6 24.89M 34.36M 28.85M 117.2M 150.32M 131.07M
2027-03-31 6 13.01M 17.97M 15.09M 115.93M 148.69M 129.65M
2026-12-31 6 33.24M 45.9M 38.54M 119.77M 153.62M 133.94M
2026-09-30 13 20.97M 31.21M 26.82M 122.39M 141.61M 132.06M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 6 334.81M 429.43M 374.42M 2 0.19406 0.26797 0.225
2027-09-30 6 331.88M 425.67M 371.15M 2 0.18543 0.25606 0.215
2027-06-30 6 328.24M 421M 367.07M 2 0.20412 0.28187 0.23667
2027-03-31 6 324.68M 416.44M 363.1M 3 0.10673 0.14738 0.12375
2026-12-31 6 335.44M 430.23M 375.12M 3 0.27264 0.37648 0.31611
2026-09-30 13 342.78M 396.6M 369.86M 7 0.17201 0.25601 0.22001